TIANJIN PHAR.DA REN S YC1

TIANJIN PHAR.DA REN S YC1

Share · CNE100000924 · A0Q272 (XSES)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of TIANJIN PHAR.DA REN S YC1
No Price
Closing Price XSES 29.04.2026: 3,20 USD
29.04.2026 02:59
Current Prices from TIANJIN PHAR.DA REN S YC1
ExchangeTickerCurrencyLast TradePriceDaily Change
XSES: SGX
SGX
T14.SI
USD
29.04.2026 02:59
3,20 USD
-0,010 USD
-0,31 %
Invested Funds

The following funds have invested in TIANJIN PHAR.DA REN S YC1:

Fund
iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF USD (Dist)
Vol. in million
27,15
Percentage (%)
0,03 %
Company Profile for TIANJIN PHAR.DA REN S YC1 Share
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, it provides logistics, stocks, equipment installation, and medicine processing services; medicine inspection and testing services; and pharmaceutical consultancy services. The company sells its medicinal products under its own brand to the wholesalers; and purchases medicinal products under other brands from distributors and sells these to other wholesalers. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was incorporated in 1992 and is based in Tianjin, the People's Republic of China.

Company Data

Name TIANJIN PHAR.DA REN S YC1
Company Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Website https://www.zhongxinp.com
Primary Exchange XSES Frankfurt
WKN A0Q272
ISIN CNE100000924
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Lei Wang
Market Capitalization 4 Mrd.
Country China
Currency EUR
Employees 4,6 T
Address Zhong Xin Mansion, 300193 Tianjin
IPO Date 2000-01-03
Dividends from 'TIANJIN PHAR.DA REN S YC1'
Ex-Date Dividend per Share
30.01.2026 0,35 USD
25.06.2025 0,18 USD
02.07.2024 0,18 USD
26.05.2023 0,21 USD
24.05.2022 0,10 USD
15.06.2021 0,06 USD
15.06.2020 0,06 USD
01.07.2019 0,04 USD
28.06.2018 0,04 USD
28.06.2017 0,03 USD

Stock Splits

Date Split
30.06.2010 2:1

Ticker Symbols

Name Symbol
Frankfurt 2TZ.F
SGX T14.SI
More Shares
Investors who hold TIANJIN PHAR.DA REN S YC1 also have the following shares in their portfolio:
BNPP EM.EQUITY PR.CAP
BNPP EM.EQUITY PR.CAP Fund
TREASURY CORPVICT. 2026
TREASURY CORPVICT. 2026 Bond